Inhibition of phosphatidylinositol 3-kinase

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.1, 1998-07, pp. : 97-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

Current Drug Discovery Technologies, Vol. 11, Iss. 2, 2014-06 ,pp. : 113-126

Bentham Science Publishers

Access to resources Recommend Favorite

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

By Fujino H. Regan J.W.

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 335-340

Elsevier

Access to resources Recommend Favorite

New phosphatidylinositol 3-kinase inhibitors for cancer

By Bowles Daniel W Jimeno Antonio

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 507-518

Informa Healthcare

Access to resources Recommend Favorite

Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2839-2854

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets

Current Drug Targets, Vol. 12, Iss. 7, 2011-06 ,pp. : 1056-1081

Bentham Science Publishers

Access to resources Recommend Favorite